Healthpoint clinical trials

Acquired by Smith & Nephew, Inc., Dec 21, 2012 · source ↗

The registry lists 34 studies whose lead sponsor is Healthpoint. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 2, 2017.

Studies

Recruiting first, then most recently updated. Showing 34 of 34. All Smith & Nephew, Inc. studies →

• Safety Follow-Up to HP 802-247-09-015CompletedNCT00900029

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2CompletedNCT01737762Phase 3

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Study of Survival Duration for Donor Skin Cells in Skin Biopsy WoundsCompletedNCT01190865Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery PatientsCompletedNCT01359735Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247CompletedNCT01970657

  Sponsor listed in the registry: Healthpoint · First submitted after Healthpoint became part of Smith & Nephew, Inc.

• Dose Finding Study of HP802-247 in Venous Leg UlcersCompletedNCT00852995Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg UlcersTerminatedNCT01853384Phase 3

  Sponsor listed in the registry: Healthpoint · First submitted after Healthpoint became part of Smith & Nephew, Inc.

• A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg UlcersTerminatedNCT02154087Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted after Healthpoint became part of Smith & Nephew, Inc.

• Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg UlcersCompletedNCT01656889Phase 3

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Santyl Applications to Diabetic Foot UlcersCompletedNCT02111291Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted after Healthpoint became part of Smith & Nephew, Inc.

• Study to Determine if Fibrin Affects the Ability of a Wound to HealCompletedNCT01253135Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Study of Oasis Ultra in Diabetic Foot UlcersCompletedNCT01835379Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted after Healthpoint became part of Smith & Nephew, Inc.

• Using Santyl on Diabetic Foot UlcersCompletedNCT01408277Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Contact Sensitization Potential of 828 OintmentCompletedNCT00767676Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Cumulative Irritation Potential of 828 OintmentCompletedNCT00767455Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord InjuryTerminatedNCT01433159Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg UlcerStatus unknownNCT01658618

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness WoundsCompletedNCT00971048Not applicable

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Clinical Evaluation of the Phototoxic Potential of Xenaderm OintmentCompletedNCT00644917Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Evaluation of Effects of HP828-101 for Moisture Associated Skin DamageTerminatedNCT01108523Early Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on HealingCompletedNCT00713349Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Post Treatment Care After Chemical Peel or Laser ResurfacingWithdrawnNCT01135290Early Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home SettingWithdrawnNCT00714519Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot UlcersCompletedNCT01143727Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Wound Edge Changes Following Treatment With SantylCompletedNCT01197898Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot UlcersCompletedNCT01143714Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar FormationCompletedNCT01705860

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Santyl vs. Sharp Debridement of Diabetic Foot WoundsCompletedNCT01056198Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• HP011-101, HP828-101, and Standard Care for Pressure UlcersWithdrawnNCT01273428Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Using Santyl or Bacitracin on Second Degree BurnsWithdrawnNCT01516463Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• A Pilot Study of HP802-247 in Dystrophic Epidermolysis BullosaWithdrawnNCT01528306Phase 2

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Effect of Collagenase on Healing and ScarringCompletedNCT00651820Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• OASIS Wound Matrix (Oasis) Mechanism of ActionCompletedNCT00570141Phase 4

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.

• Clinical Evaluation of the Photoallergy Potential of Xenaderm OintmentCompletedNCT00645164Phase 1

  Sponsor listed in the registry: Healthpoint · First submitted before Healthpoint became part of Smith & Nephew, Inc.